Psyadon Pharmaceuticals (United States)
- Research works
- 36 ▼ 94% vs 2018-21
- Citations
- 554 15.2 per fractional work
- Top-10% rate
- 9.6% all institutions 10.0%
- Open access
- 11% world 40%
- International
- 26% world 18%
Not ranked overall: Psyadon Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Psyadon Pharmaceuticals (United States) work in?
In all years, 49% of research at Psyadon Pharmaceuticals (United States) is in Life Sciences, 37% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (45%), Medicine (35%), Chemistry (8%). It does 2.5× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 14 fields, with their numbers
- Life Sciences1849.3%
- Health Sciences1437.1%
- Medicine1335.1%
- Nursing11.8%
- Health Professions00.2%
- Physical Sciences412.2%
- Chemistry37.9%
- Engineering11.8%
- Computer Science00.9%
- Environmental Science00.9%
- Materials Science00.8%
- Social Sciences01.3%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at Psyadon Pharmaceuticals (United States)?
Ranked on the quality score, Ricardo Cibotti, Deog Joong Kim and Chang‐Ho Ahn lead among researchers whose main affiliation is Psyadon Pharmaceuticals (United States).
- 1
Ricardo Cibotti
United States · #3,786,774 worldwide 21 citations · 33 works
- 2
Deog Joong Kim
United States · #4,560,238 worldwide 461 citations · 30 works
- 3
Chang‐Ho Ahn
United States · #5,332,615 worldwide 626 citations · 50 works
Which keywords describe research at Psyadon Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Tumor Microenvironment, Therapeutic Targets, Regulation, Cancer Therapy, Antiretroviral Therapy, Cancer Progression and Enzyme Regulation.
- DNA Damage
- Inflammation
- Cancer
- Synthesis
- Drug Discovery
- Arginine Deprivation
- DNA Structure
- Nanoparticles
- Integrase Inhibitors
- p53
- MDM2
- Tumor Targeting
- Chemotherapy
- Drug Resistance
- RNA methylation
- Enzyme Regulation
- Cancer Progression
- Regulation
- Tumor Microenvironment
- Immunotherapy
- Therapeutic Targets
- Antiretroviral Therapy
- Cancer Therapy
- Nucleotide Metabolism
- m6A-seq
- Apoptosis
- Gene Therapy
- Cell Cycle
- Tumor Suppression
- HIV Infection
- Medicinal Chemistry
- Genomic Stability
- G-Quadruplexes
- Bacterial Therapy
- Oxidative Stress
- Biological Evaluation
- Epidemiology
- Treatment
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 38 words, with their numbers
- Immunotherapy3▲ 14×8 topics
- Tumor Microenvironment3▲ 25×6 topics
- Therapeutic Targets3▲ 32×4 topics
- Regulation3▲ 12×2 topics
- Antiretroviral Therapy2▲ 30×2 topics
- Cancer Progression2▲ 30×2 topics
- Cancer Therapy2▲ 11×4 topics
- Enzyme Regulation2▲ 140×1 topic
- Nucleotide Metabolism2▲ 194×1 topic
- RNA methylation2▲ 85×1 topic
- m6A-seq2▲ 85×1 topic
- Drug Resistance2▲ 21×3 topics
- Apoptosis2▲ 16×3 topics
- Chemotherapy2▲ 8.2×7 topics
- Gene Therapy2▲ 21×2 topics
- Tumor Targeting2▲ 43×3 topics
- Cell Cycle2▲ 96×2 topics
- MDM22▲ 125×1 topic
- Tumor Suppression2▲ 48×2 topics
- p532▲ 125×1 topic
- HIV Infection2▲ 43×1 topic
- Integrase Inhibitors2▲ 128×1 topic
- Medicinal Chemistry2▲ 14×7 topics
- Nanoparticles2▲ 4.0×4 topics
- Genomic Stability2▲ 52×2 topics
- DNA Structure2▲ 68×1 topic
- G-Quadruplexes2▲ 68×1 topic
- Arginine Deprivation1▲ 87×1 topic
- Bacterial Therapy1▲ 87×1 topic
- Drug Discovery1▲ 8.7×4 topics
- Oxidative Stress1▲ 1.97×6 topics
- Synthesis1▲ 5.7×6 topics
- Biological Evaluation1▲ 24×4 topics
- Cancer1▲ 2.1×7 topics
- Epidemiology1▼ 0.74×6 topics
- Inflammation1▲ 1.30×3 topics
- Treatment1▲ 2.4×3 topics
- DNA Damage1▲ 21×2 topics
Which research topics does Psyadon Pharmaceuticals (United States) publish most on?
By volume in 2022-now: Renal Diseases and Glomerulopathies, Organ Transplantation Techniques and Outcomes, Healthcare Policy and Management and Emergency and Acute Care Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Renal Diseases and Glomerulopathies Nephrology 0 works
- 2 Organ Transplantation Techniques and Outcomes Surgery 0 works
- 3 Healthcare Policy and Management Economics and Econometrics 0 works
- 4 Emergency and Acute Care Studies Emergency Medicine 0 works
- 5 Renal Transplantation Outcomes and Treatments Transplantation 0 works
- 6 Xenotransplantation and immune response Surgery 0 works
- 7 Pancreatic function and diabetes Surgery 0 works
- 8 Transplantation: Methods and Outcomes Surgery 0 works
- 9 T-cell and B-cell Immunology Immunology 0 works
- 10 Diabetes and associated disorders Genetics 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Psyadon Pharmaceuticals (United States)'s research output changed?
Output in 2022-2025 was 94% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Psyadon Pharmaceuticals (United States) as a percentage of every work published that year, 0.0000037% in 2023.
Fractional works of Psyadon Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Germantown
- American College of Veterinary Surgeons
- Avalon Pharma (United States)
- Intelligent Fusion Technology (United States)
- Senseonics (United States)
- Earth Networks (United States)
- Herrick Technology Laboratories (United States)
- Zalgen (United States)
- C-Motion (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Psyadon Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.